SPARC Q2 Results | Net loss widens to ₹107 crore, revenue dives 39% to ₹13 crore

Shares of Sun Pharma Advanced Research Company Ltd ended at ₹205.55, down by ₹10.55, or 4.88% on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *